Incyte Corp (NASDAQ:INCY)

79.62
Delayed Data
As of Nov 30
 +1.83 / +2.35%
Today’s Change
63.40
Today|||52-Week Range
84.86
+8.47%
Year-to-Date

Today’s Trading

Previous close77.79
Today’s open77.81
Day’s range77.58 - 79.67
Volume72,013
Average volume (3 months)1,346,674
Market cap$17.4B
Data as of 4:01pm ET, 11/30/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-58.39%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+11.98%
P/E ratio20.2
Price/Sales5.46
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
VTRSViatris Inc-0.15-1.34%
SGENSeagen Inc+4.02+3.43%
UTHRUnited Therapeutics ...+8.65+3.19%
HZNPHorizon Therapeutics...+21.51+27.30%
Data as of 4:01pm ET, 11/30/2022

Financials

Next reporting dateFebruary 16, 2023
EPS forecast (this quarter)$0.31
Annual revenue (last year)$3.0B
Annual profit (last year)$948.6M
Net profit margin31.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Wilmington, Delaware

Forecasts